Jane Street
CARM

Jane Street’s Carisma Therapeutics CARM Stock Holding History

Jane Street’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-150,810
Closed -$59.1K – 10835
2025
Q2 		$59.1K Buy
+150,810
New +$40.4K ﹤0.01% 9133
2024
Q3 		– Sell
-159,879
Closed -$243K – 9623
2024
Q2 		$243K Buy
+159,879
New +$238K ﹤0.01% 8125
2023
Q4 		– Sell
-36,328
Closed -$154K – 9222
2023
Q3 		$154K Buy
36,328
+230
+0.6% +$1.46K ﹤0.01% 7769
2023
Q2 		$317K Buy
+36,098
New +$197K ﹤0.01% 7039
2023
Q1 		– Sell
-14,250
Closed -$174K – 9086
2022
Q4 		$174K Buy
+14,250
New +$150K ﹤0.01% 7771
2022
Q3 		– Sell
-6,018
Closed -$98K – 9740
2022
Q2 		$98K Buy
6,018
+5,007
+495% +$57.3K ﹤0.01% 8650
2022
Q1 		$12K Sell
1,011
-22,253
-96% -$311K ﹤0.01% 10038
2021
Q4 		$379K Sell
23,264
-22,942
-50% -$462K ﹤0.01% 7754
2021
Q3 		$733K Buy
46,206
+32,287
+232% +$1.55M ﹤0.01% 6547
2021
Q2 		$1.29M Buy
13,919
+6,190
+80% +$395K ﹤0.01% 5258
2021
Q1 		$401K Buy
7,729
+5,766
+294% +$272K ﹤0.01% 7196
2020
Q4 		$53K Sell
1,963
-4,625
-70% -$117K ﹤0.01% 7308
2020
Q3 		$184K Buy
6,588
+5,534
+525% +$111K ﹤0.01% 6481
2020
Q2 		$15K Buy
+1,054
New +$14.2K ﹤0.01% 6980
2019
Q3 		– Sell
-1,603
Closed -$48K – 5113
2019
Q2 		$48K Buy
+1,603
New +$48K ﹤0.01% 4959
2019
Q1 		– Sell
-1,429
Closed -$41K – 5037
2018
Q4 		$41K Buy
+1,429
New +$45.6K ﹤0.01% 4740

Other funds holding CARM

MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return

Jane Street's CARM Position: Q3 2025 in Review

Jane Street sold out of Carisma Therapeutics (CARM) in Q3 2025, closing a stake of 150,810 shares — an estimated $59.1K sold.

Jane Street first reported a position in CARM in Q4 2018 and held it in 16 quarters. The position peaked at $1.29M in Q2 2021. 33 funds tracked by Wall St. Rank hold CARM as of Q3 2025.

  • Jane Street reported no remaining Carisma Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Jane Street sold 150,810 Carisma Therapeutics shares in Q3 2025, an estimated $59.1K.
  • Jane Street first reported a position in Carisma Therapeutics in Q4 2018 and held it in 16 quarters.
  • Jane Street's Carisma Therapeutics position peaked at $1.29M in Q2 2021.
  • 33 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.